Company: OTSA
Filing Date: 2025-07-16
Form Type: F-1/A
Source: 0001213900-25-064434
Chunk: 161

Company: OTSAW Ltd
Filing Date: 2025-07-16
Form: F-1/A
Chunk 161
---
 advantages. Compared to similar mapping technology developed by other companies, our 3D SLAM technology is able to build the map more efficiently, and has been proven for application in external unmapped environments. Furthermore, our scalable software and hardware platforms enable us to collaborate with our customers to expand the service capabilities of our AMRs and robots to provide tailored, commercially viable, and diversified applications and solutions for varied service scenarios. In addition, we consistently combine the best intelligence from both humans and machines to improve algorithms, boost performance, and ensure safety. Our AMRs’ sophisticated analytics, reporting, and AI capabilities may significantly differentiate us from our competitors. As of the date of prospectus, we have 2 trademarks and 5 design registrations registered, as well as 1 pending trademark application, relating to our products in Singapore. We have 1 patent registered and 1 pending patent application in Singapore, and 1 patents registered in the United States, respectively. The registered patents are related to our 3D SLAM technology, and the pending patent application is related to our UV -CLED disinfection solutions. We will continue to monitor future technological developments for optimal integration into our products to sustain our position as a market leader. Offering a Highly Scalable AMR, Robotics, UV-C LED Disinfection Ecosystem with a Wide-Array of Facilities Management Industry Solutions We are one of the few market players that have the right technology to offer a broad spectrum of robotic applications at a commercially -viablescale. Most existing market players are either niche players in their respective applications or have a limited product offering or use case. Because our core software technologies and robotics platform are highly scalable, we are well -positionedto tap into many markets with tremendous monetization opportunities and rapidly expand our customer base. As our business grows, we will benefit from economies of scale and improved operational efficiency. One of the most illustrative cases evidencing the scalability of our ecosystem is our O -RXrobot, the world’s first autonomous disinfection robot to utilize UV -CLED technology to help combat the COVID -19pandemic. We produced the first O -RXprototype in April 2020 and brought it to market in June 2020, a mere 3 months after the WHO declared COVID -19a global pandemic, demonstrating the high scalability of our existing software and hardware platform. Our AMRs, robots, and other products can also quickly integrate into any type and size of the facility and cater to the diverse and changing needs of organizations across industry sectors. As of